Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TPH2 polymorphisms may modify clinical picture in treatment-resistant depression.

Neuroscience letters - 16 Oct 2009

Anttila Sami, Viikki Merja, Huuhka Kaija, Huuhka Martti, Huhtala Heini, Rontu Riikka, Lehtimäki Terho, Leinonen Esa

Abstract excerpt

The association of two tryptophan hydroxylase 2 (TPH2) polymorphisms and treatment response in electroconvulsive therapy (ECT) and the risk of depression was studied. The patient sample consisted of 119 subjects with treatment-resistant major depressive disorder who were treated with ECT. Treatme...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder and Treatment
Share to Depressive Disorder, Major
Share to TPH2 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Polymorphism, Genetic

Share to Treatment of Major Depression

Share to Tryptophan Hydroxylase

Source

Identifiers

PMID: 19679166
DOI: 10.1016/j.neulet.2009.08.018

Genes

TPH2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19679166-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TPH2 polymorphisms may modify clinical picture in treatment-resistant depression.PMID 19679166Read ↗

Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression.Semantic proximity Read ↗

TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response.Semantic proximity Read ↗

Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment.Semantic proximity Read ↗

[Association of TPH2 gene polymorphism with response to antidepressant treatment among ethnic Han Chinese population].Semantic proximity Read ↗

Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.Semantic proximity Read ↗

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.Semantic proximity Read ↗

Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.Semantic proximity Read ↗

Association between single nucleotide polymorphisms of TPH1 and TPH2 genes, and depressive disorders.Semantic proximity Read ↗

Tryptophan hydroxylase 2 gene is associated with major depressive disorder in a female Chinese population.Semantic proximity Read ↗

No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression.Semantic proximity Read ↗

Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.Semantic proximity Read ↗

Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.